Evidence map›Paper›PMID 26115041›Full record

ArticleScientific reports2015

SNP rs2057482 in HIF1A gene predicts clinical outcome of aggressive hepatocellular carcinoma patients after surgery.

Xu Guo, Deyang Li, Yibing Chen, Jiaze An, Kan Wang, Zhuding Xu, Zhinan Chen, Jinliang Xing

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Genetic variability ofRadiology and oncology · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. SNP rs2240688 inTranslational cancer research · 2020
    Article
  12. Review
  13. HIF-1A gene polymorphisms and its protein level in patients with rheumatoid arthritis: a case-control study.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2018
    Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Hypoxia-inducible factors as molecular targets for liver diseases.Journal of molecular medicine (Berlin, Germany) · 2016
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Xu GuoState Key Laboratory of Cancer Biology, Cell Engineering Research Center &Department of Cell Biology, Fourth Military Medical University, Xi'an, China.
Deyang LiState Key Laboratory of Cancer Biology, Cell Engineering Research Center &Department of Cell Biology, Fourth Military Medical University, Xi'an, China.
Yibing ChenExperimental Teaching Center of Basic Medicine, Fourth Military Medical University, Xi'an, China.
Jiaze AnDepartment of Hepatobiliary Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Kan WangDepartment of Pain treatment, Tangdu Hospital, The Fourth Military Medical University, Xi'an, China.
Zhuding XuDepartment of liver Surgery, Eastern Hepatobiliary Surgery Hospital, The Second Military Medical University, Shanghai, China.
Zhinan ChenState Key Laboratory of Cancer Biology, Cell Engineering Research Center &Department of Cell Biology, Fourth Military Medical University, Xi'an, China.
Jinliang XingState Key Laboratory of Cancer Biology, Cell Engineering Research Center &Department of Cell Biology, Fourth Military Medical University, Xi'an, China.
Air Force Medical University · CNEastern Hepatobiliary Surgery Hospital · CNXijing Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypoxia-inducible factor 1α (HIF-1α) plays an important role in tumor growth and metastasis. Genetic variations of HIF1A gene have been shown to influence the developing risk and prognosis in many types of human malignancies. However, their association with clinical outcomes of hepatocellular carcinoma (HCC) patients remains unclear. To investigate the predictive role of single nucleotide polymorphisms (SNPs) in HIF1A gene in HCC patients' outcomes, we genotyped three functional SNPs (rs2057482, rs1957757 and rs2301113) in HIF1A gene and assessed their associations with clinicopathological parameters and prognosis of 492 surgical HCC patients. The patients with variant alleles (CT+TT) of SNP rs2057482 had a significantly lower recurrence risk when compared with patients with the CC genotype. In stratified analysis, the protective effect of rs2057482 CT+TT genotype was more evident in patients with adverse strata, compared with patients with favorable strata. Additionally, strong joint predictive effect between rs2057482 genotypes and AFP level, stage or differentiation were observed. Functional assay also indicated the significant effect of rs2057482 on gene expression. In conclusion, SNP rs2057482 in HIF1A gene is significantly associated with clinical outcomes of Chinese HCC patients after surgery, especially in those with aggressive status, which warrants further validation in other patient populations.

Indexed as

Polymorphism, Single NucleotideAsian PeopleCarcinoma, HepatocellularCell Line, TumorChinaFemaleFollow-Up StudiesGene FrequencyGenotypeHEK293 CellsHumansHypoxia-Inducible Factor 1, alpha SubunitLiver NeoplasmsMaleMiddle AgedNeoplasm Recurrence, LocalHypoxia-Inducible Factor 1, alpha Subunit

Identifiers

PMID26115041
PMCPMC4481773
OpenAlexW2273218586

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.